Home page Description:
Since Fall 2015, 1 Affiliate Scientist and 33 Clinician Investigators have joined Krembil.
Posted On: March 31, 2017
Once per year, Krembil Director Dr. Donald Weaver hosts an event to recognize the Institute’s new research appointments. This year’s event took place on March 24th, at which Affiliate Scientist Dr. Clement Hamani and 33 newly appointed Clinician Investigators were welcomed to the Krembil family.
It is important to note that, although new to the Institute, many of the Clinician Investigators are not new to research; they have been performing research at UHN for many years.
The Clinician Investigator appointment was launched in Fall 2015 to facilitate and advance clinical research at the Hospital. Once appointed as a member of the Institute, Clinician Investigators receive access to select resources. For example, they become eligible for internal small equipment and trainee support grant competitions. They also receive access to grant development and research dissemination services.
Most Clinician Investigators are physicians or surgeons who spend a majority of their time dedicated to clinical service, but they also lead significant research projects that span all three of Krembil’s research pillars (ie, neuroscience, arthritis and vision). For example: Dr. Michael Brent studies vision loss and sight-restoring treatment, specifically related to age-related macular degeneration, diabetic retinopathy and vascular occlusive diseases; Dr. Christian Veillette collects patient outcomes data and uses predictive analytics to better inform clinical decision making; and Dr. Roger McIntyre studies the connection between mood disorders and cognitive impairment, with the aim of improving diagnostics and treatment.
Interested applicants must be actively performing clinical research and meet the criteria for research excellence, evaluated based on research funding; publication record; invited lectureships; engagement in teaching and mentorship roles; and participation on committees. Interested applicants should submit a letter of interest and a current CV to the Krembil administration office: krembil@uhnresearch.ca.
It is important to note that, although new to the Institute, many of the Clinician Investigators are not new to research; they have been performing research at UHN for many years.
The Clinician Investigator appointment was launched in Fall 2015 to facilitate and advance clinical research at the Hospital. Once appointed as a member of the Institute, Clinician Investigators receive access to select resources. For example, they become eligible for internal small equipment and trainee support grant competitions. They also receive access to grant development and research dissemination services.
Most Clinician Investigators are physicians or surgeons who spend a majority of their time dedicated to clinical service, but they also lead significant research projects that span all three of Krembil’s research pillars (ie, neuroscience, arthritis and vision). For example: Dr. Michael Brent studies vision loss and sight-restoring treatment, specifically related to age-related macular degeneration, diabetic retinopathy and vascular occlusive diseases; Dr. Christian Veillette collects patient outcomes data and uses predictive analytics to better inform clinical decision making; and Dr. Roger McIntyre studies the connection between mood disorders and cognitive impairment, with the aim of improving diagnostics and treatment.
Interested applicants must be actively performing clinical research and meet the criteria for research excellence, evaluated based on research funding; publication record; invited lectureships; engagement in teaching and mentorship roles; and participation on committees. Interested applicants should submit a letter of interest and a current CV to the Krembil administration office: krembil@uhnresearch.ca.